VC  Arcus Ventures

     Office Locations:

One Grand Central Place
60 East 42nd Street, Suite 1610
New York, NY 10165
Phone: 212-785-2236
Fax: 212-785-2237



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private equity. AV is dedicated to investing in oncology focused companies with innovative biopharmaceuticals and or new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Chad Hellmann MBA CFO
    James Dougherty MD, MBA General Partner
    Rubin Bakalli Administrative Manager
    Steven Soignet MD General Partner


    Portfolio companies include:

      Clear Vascular
        web link

      Cleave Biosciences
        web link

      Epic Sciences
        web link

      Exosome Diagnostics
        web link

        web link

        web link

      MIR Preclinical Services
        web link

      Palyon Medical
        web link

      T2 Biosystems
        web link

      Tracon Pharmaceuticals
        web link

      Vascular Pathways
        web link

      XTuit Pharmaceuticals
        web link


    Recent News: